JCVI: [Escitalopram for Intervention of Psychiatric Adverse Events During Peginterferon-alfa-2a and Ribavirin Treatment for Chronic Hepatitis C].
 
 
Section Banner

Publications

Citation

Qi MH, Zhou B, Su ML, Pan JY, Zhang H

[Escitalopram for Intervention of Psychiatric Adverse Events During Peginterferon-alfa-2a and Ribavirin Treatment for Chronic Hepatitis C].

Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University. 2013 Jul 20; 33: 1012-6.

External Citation

Abstract

To evaluate the risk factors of psychiatric adverse events associated with PEG interferon and ribavirin treatment for chronic hepatitis C and assess the efficacy of escitalopram intervention for these adverse effects.